Para-Iodomethamphetamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
para-Iodomethamphetamine (PIMA), also known as 4-iodo-N-methylamphetamine (4-IMA) or as D-9, is a monoaminergic drug of the amphetamine family related to para-chloroamphetamine (PCA).[1][2] It is the N-methyl analogue of para-iodoamphetamine (PIA).[1][2] The drug is active in producing behavioral effects in animals, including hallucinogen-like effects.[2] However, it is unclear whether these effects actually represent hallucinogenic reactions.[2] PIMA does not appear to have been assessed, but other para-halogenated amphetamines, such as PCA, are known to act as monoamine releasing agents and as monoaminergic neurotoxins.[3][4][5][6][7] They have not proved to be psychedelic in humans.[8] PIMA was studied by Joseph Knoll and colleagues in the 1960s or 1970s.[2]
- None
| |
| Clinical data | |
|---|---|
| Other names | PIMA; 4-Iodo-N-methylamphetamine; 4-IMA; D-9 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H14IN |
| Molar mass | 275.133 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
